Accessibility Menu

Is Teva's Dividend Safe?

Here's what you need to know about Teva Pharmaceuticals (TEVA) patent expiration on Copaxone and the potential impact it may have on its dividend.

By Todd Campbell Jun 6, 2014 at 6:00PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.